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This study aimed to investigate the therapeutic eﬀects of the water extract of leaves of Vitis coigne-
tiae Pulliat (VCPL) on nonalcoholic steatohepatitis (NASH) with advanced ﬁbrosis,  as our previous 
study exhibited its preventive eﬀect on NASH.  The NASH animal model [PCT/JP2007/52477] was 
prepared by loading recurrent and intermittent hypoxemia stress to a rat with fatty liver,  which 
resembled the condition occurring in patients with obstructive sleep apnea (OSA) and fatty liver,  who 
have a high incidence of NASH.  Intermittent hypoxemia stress is regarded as a condition similar to 
warm ischemia followed by re-oxygenation,  which induces oxidative stress (OS).  The daily 100 or 
300mg/kg VCPL administrations were performed for 3 weeks perorally beginning at the time of 
detection of advanced liver ﬁbrosis.  The therapeutic eﬃcacy of VCPL on NASH was demonstrated by 
the reduction of the leakage of hepato-biliary enzymes and the amelioration of liver ﬁbrosis.  The OS 
elevation in NASH rats was measured based on the derivation of reactive oxygen species from liver 
mitochondrial energy metabolism and on the decrease in plasma SOD-like activity.  The aggravation of 
inﬂammatory responses was demonstrated by the neutrophil inﬁltration (elevated myeloperoxidase 
activity) and the progression of ﬁbrosis in the livers of NASH rats.  In addition,  the NASH rats with-
out VCPL treatment also exhibited activation of nuclear factor-κB,  a key factor in the link between 
oxidative stress and inﬂammation.  All of these changes were reduced dose-dependently by the VCPL 
administration.  These ﬁndings indicate that VCPL may improve hepatic ﬁbrosis or at least suppress 
the progression of NASH,  by breaking the crosstalk between OS and inﬂammation.
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onalcoholic steatohepatitis (NASH),  one of most 
common liver diseases,  is characterized by 
necroinﬂammatory activity,  with nonspeciﬁc inﬂam-
matory inﬁltrates,  hepatocyte ballooning with Malloryʼs 
hyaline and occasional ﬁbrosis [1].  Although the etiol-
ogy of NASH remains unclear,  the “two-hit theory” 
describes the most widely accepted mechanism for the 
progression of NASH [2].
　 Oxidative stress (OS) is regarded as the “second 
hit” in the development of NASH,  following the “ﬁrst 
hit” of hepatic fat accumulation.  Mitochondrial dys-
function in the NASH liver causes and maintains 
overproduction of reactive oxygen species (ROS) [3,  
4].  This excessive ROS activates nuclear factor-
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kappa B (NF-κB),  induces inﬂammatory cytokines and 
a variety of other inﬂammatory factors,  and stimulates 
the hepatic stellate cells (HSCs),  which play an 
important role in ﬁbrogenesis [4,  5].  A previous 
clinical study demonstrated that the long-term admin-
istrations of vitamin E and vitamin C improved the 
ﬁbrosis in NASH patients [6].  Thus,  the regulation 
of oxidative stress could potentially contribute to the 
treatment of progressive NASH.  However,  the opti-
mum treatment for NASH remains to be established.
　 It is widely recognized that grapes confer health 
beneﬁts through their potent antioxidative abilities,  
which are believed to play a major role in the so-
called “French paradox. ” Vitis coignetiae Pulliat,  or 
Yamabudo in Japanese,  is a Japanese wild grape spe-
cies,  and shows very high levels of polyphenols such 
as anthocyanins in both the fruit and peel,  compared 
with other grape species [7].  As such,  it has been 
widely been utilized in drinks such as juice and wine.  
Several biological properties have been attributed to 
Vitis coignetiae Pulliat,  including high free-radical-
scavenging activity and resistance to photodecomposi-
tion of anthocyanin pigments [8].  We focused our 
attention on leaves of Vitis coignetiae Pulliat (VCPL),  
because the same functional constituents found in the 
fruit and the peel are also present in the leaves,  as 
they produce and provide various components to 
plants.  The safety of VCPL as a food is secured,  
because,  the traditional custom of serving leaves of 
Vitis coignetiae Pulliat as an edible materials exists in 
Hiruzen district,  Okayama.
　 It has been reported that the rate of NASH devel-
opment is 7-fold higher in patients with obstructive 
sleep apnea (OSA) and fatty liver,  compared to those 
with fatty liver,  so the association of OSA and NASH 
has been the target of growing attention [9,  10].  
Here,  we used a clinically relevant rat model of 
NASH (patent application no.  PCT/JP2007/52477).  
Rats were fed a CDHF diet continuously for 4 weeks 
to induce steatosis,  and then exposed to recurrent and 
intermittent hypoxemia stress to induce liver dysfunc-
tion [11] within a relatively short period of time.  
Recurrent and intermittent hypoxemia is considered a 
condition similar to warm ischemia-reperfusion,  which 
is accepted as a cause of oxidative stress in patients 
with OSA [9,  10].
　 Using this morbid model of NASH,  we previously 
demonstrated that VCPL has a preventive eﬀect on 
the progression of NASH through its high antioxida-
tive activity and its ability to attenuate the induction 
of cytochrome P450 2E1 (CYP2E1) [12] for which a 
role in ROS production,  oxidative stress,  and lipid 
peroxidation has been implicated.  In the present 
study,  we aimed to investigate the therapeutic eﬀect 
of VCPL on NASH with liver ﬁbrosis,  to focus on the 
OS from mitochondria metabolism and inﬂammatory 
responses.
Materials and Methods
　 Preparation of VCPL water extracts. The 
leaves were collected in 3 seasons (July,  September,  
and the end of October) at Hiruzen Highland (Maniwa,  
Okayama,  Japan) where the improved variety of Vitis 
coigunetiae Pulliat is cultivated on a large scale and is 
one of the special local products,  as there is suitable 
for its growth The leaves gathered in July and 
September were green,  and those gathered in October 
were red.  The water extracts were prepared from the 
VCPL from all 3 seasons as mentioned below,  and 
their antioxidative abilities were found to be very 
strong (data not shown) and similar each other.  In this 
study,  we used the water extract from the red leaves 
gathered at the end of October after post-harvest for 
the animal experiment,  because their water extract 
was superior by its beautiful red color and by its mel-
low aroma like a red wine,  compared to those from 
green leaves of July and September.  Besides the post-
harvest VCPL is advantageous as a material of func-
tional foods,  there is not the inﬂuence on fruit har-
vest.
　 The leaves were washed,  freeze-dried,  and pow-
dered.  The powder (50g) was extracted by distilled 
water (1 L) for 10min at 4℃.  The extract was ﬁl-
tered and then the solvent was evaporated to dryness 
under reduced pressure in a rotary evaporator.  The 
residual extract was freeze-dried to powder,  and used 
for the study.  To check the safety of VCPL water 
extracts,  we executed the analyses for the determina-
tion of pesticide residues and heavy metals such as 
cadmium,  lead,  arsenic and mercury in a freeze-dried 
preparation.  All of these contents in the freeze-drying 
preparation of the water extracts of VCPL were 
either under the detection limits or under the maxi-
mum residue limits for pesticides and the standards 
for the tolerance of heavy metals (data not shown) for 
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which standards have been legally established with 
regard to food ingredients pursuant to the Food sani-
tation Act.  After conﬁrming the safety of VCPL with 
respect to pesticide residues and heavy metals,  the 
water extract of VCPL was used for an animal 
experiment.
　 Animals and experimental design. Six-week- 
old male Wistar rats were purchased from Shimizu 
Animal Co.  (Kyoto,  Japan) and maintained at the 
Okayama University animal facility in accordance with 
the Okayama University Guidelines on the Care and 
Use of Laboratory Animals.  Rats were housed in 
individual cages in air-conditioned rooms with a con-
trolled 12-h light-dark cycle.  The rats were allowed 
to acclimate to the animal facility and were provided 
free access to diets and water ad libitum.
　 The NASH rat model [PCT/JP2007/52477] was 
prepared by our method [11].  The rats were fed 
either a standard chow diet for rodents (MF labora-
tory chow; Oriental Yeast Co.,  Tokyo,  Japan) (the 
Control group; n＝5),  or a choline-deﬁcient high-fat 
(CDHF) diet (Oriental Yeast Co.,  Tokyo,  Japan) (n
＝30) throughout the experimental period of 13 
weeks.  Fatty liver was formed by the feeding with 
CDHF for 4 weeks.  Then rats with fatty liver were 
divided into 3 groups to equalize their body weight.  
Beginning in the ﬁfth week,  the fatty liver rats were 
treated with intraperitoneal injection of 40mg/kg of 
sodium nitrite (NaNO2) (Nacalai Tesque Inc.,  Kyoto,  
Japan) every day to induce methemoglobinemia (inter-
mittent hypoxemia stress) for 9 weeks (NASH group;  
n＝10).  In our previous study,  we demonstrated that 
the advanced ﬁbrosis of NASH appeared 6 weeks 
after the injection of NaNO2 [11].  Thus,  the oral 
VCPL administration was performed during the last 
3 weeks,  with a dose of 100mg/kg/day VCPL in the 
NASH＋VCPL 100 group (n＝10),  and 300mg/kg/
day VCPL in the NASH＋VPCL 300 group (n＝10).
　 At the end of the 13-week experimental period,  the 
rats were sacriﬁced under light ether anesthesia,  
blood was collected from the inferior vena cava for 
plasma analysis,  and the livers were resected for 
histopathological and biochemical analyses to deter-
mine OS-related injuries and the VCPL eﬃcacy,  and 
to investigate the mechanism.
　 Leakages of hepato-biliary enzymes. Plasma 
AST and ALT activities were measured using a com-
mercially available kit,  Transaminase CII-test Wako 
(Wako Pure Chemicals,  Osaka,  Japan).  The activity 
of alkaline phosphatase (ALP) was estimated from the 
released amounts of p-nitrophenol as measured by the 
absorbance at 410nm.
　 Liver triglycerides. The supernatant fraction 
obtained by the centrifugation of 5ｵ liver homogenate 
with 0.25 M sucrose Tris-HCl buﬀer containing 0.1 M 
potassium chloride (KCl) at 200g for 10min was sub-
mitted for determination of liver triglycerides using a 
quantitative assay kit for triglycerides (Wako Pure 
Chemical Industries,  Osaka,  Japan).
　 Liver histopathology. Liver tissues were ﬁxed 
in 10ｵ formalin,  embedded in paraﬃn and sectioned 
at a thickness of 4µm.  The liver sections were stained 
with hematoxylin-eosin and Massonʼs trichrome stain-
ing methods.  Evaluations of histopathological changes 
such as fat accumulation and ﬁbrosis in the liver were 
performed by a microscopic observation and captured 
images,  using a digital light microscope (Olympus,  
Tokyo,  Japan).  The blue staining parts in the liver 
tissue sections stained with Massonʼs trichrome stain 
are the collagen-rich ﬁbrotic regions and the connec-
tive tissues.  To assess the liver ﬁbrosis,  the blue 
parts in the digital images of preparations with 
Massonʼs trichrome stain were measured using image 
analysis software,  WinROOF (Mitani Corp.,  Fukui,  
Japan).
　 Radical trapping studies. The antioxidative 
activity of rat plasma was estimated according to the 
ability to scavenge superoxide anion (O2•ﾝ),  which in 
turn was determined with an electron spin resonance 
(ESR) spectrometer (JES-RE1X JEOL RE-1X; JEOL,  
Tokyo,  Japan) connected to a data analyzer (WIN-
RAD; Radical Research Inc.,  Tokyo,  Japan) using 
5,5-dimethyl-1-pyrroline-1-oxide (DMPO) (Labotech 
Co.,  Tokyo,  Japan) as a radical-trapping reagent 
[13].  A 45µl aliquot of a 5ｵ plasma sample solution 
containing 287.5mM DMPO,  500µM hypoxanthine,  
963µM diethylenetriaminepenta-acetic acid (DETAPAC),  
5ｵ dimethyl sulfoxide (DMSO) and 0.1 U xanthine 
oxidase in a 0.1 M phosphate buﬀer solution (PBS),  
pH7.8,  was placed in a capillary glass tube (i.d.  1mm),  
which in turn was introduced into a quartz tube (i.d.  
4mm,  o.d.  5mm; LST-5HG; Labotech,  Tokyo,  Japan).  
The recording of the ESR spectrum of the sample was 
initiated 45 sec after the xanthine oxidase addition,  at 
room temperature.  The instrument conditions were as 
follows: about 9.4GHz with 100-kHz modulation fre-
319Vitis coignetiae Resolutes Liver FibrosisAugust 2012
quency,  central ﬁeld±sweep width of 335.3±5mT,  
microwave power of 8mW,  ﬁeld modulation width of 
0.079mT,  time constant of 0.1 sec,  sweep speed of 
5mT/min.  The magnetic ﬁeld was calculated from the 
splitting of divalent manganese (Mn2+),  in which the 
distance from the third to fourth signal is 8.69mT.
　 The SOD-like activity was calculated from the ratio 
of the 1st signal of the spectrum of the spin adducts of 
DMPO and O2•ﾝ (DMPO-OOH)/the 3rd signal of Mn2+,  
by ﬁtting to the calibration curve drawn with standard 
Cu,  Zn-superoxide dismutase (Cu,  Zn-SOD).
　 ROS derivation from liver mitochondria.
To examine the ROS derivation from liver mitochon-
dria,  a 35µL aliquot (500µg protein) of mitochondrial 
suspension in 0.25 M sucrose Tris-HCl buﬀer contain-
ing 0.1M KCl was mixed with 25µL of substrate 
solution containing 0.4ｵ dodecyl maltoside,  40mM 
sodium glutamate,  40mM disodium malate and 800mM 
disodium succinate in 50mM potassium phosphate buf-
fer,  pH7.4,  20µL of 4.6M DMPO and ﬁnally 1.0mM 
NADH (Oriental Yeast Co.  Osaka,  Japan),  and then 
was incubated at 37℃.  After 5min incubation follow-
ing the NADPH addition,  a 45µL aliquot of the 
above-mentioned mixture was placed into a capillary 
glass tube,  which in turn was introduced into a quartz 
tube and subjected to investigate the mitochondrial 
ROS derivation,  by the spin trapping method of ESR 
described above.
　 In this measurement,  the characteristic ESR 
spectrum of the spin adducts of DMPO and hydroxyl 
radicals (DMPO-OH) was detected.  Therefore,  the 
ROS derivation was estimated by the ratio of the 2nd 
signal intensity of the DMPO-OH spectrum/the 3rd 
signal of Mn2+.
　 Myeloperoxidase activity. Myeloperoxidase 
(MPO) activity was determined according to the 
method of Schneider et al. [14] with minor modiﬁca-
tions.  The samples of 25ｵ liver homogenate in 0.25M 
sucrose Tris-HCl buﬀer (pH7.4) were diluted to 5ｵ 
with 10mM citrate buﬀer (pH5.0) containing 0.22ｵ 
cetyltrimethylammonium chloride (CTAC; Wako Pure 
Chemicals,  Osaka,  Japan) and 0.3M sucrose,  and 
centrifugation was performed at 6,500×g for 20min 
at 4℃,  and the supernatant was used for the sample 
to determine MPO activity,  the index for the neutro-
phil inﬁltration into liver tissue.  Aliquots of 90µL of 
each liver supernatant (10mg protein/mL in 10mM 
citrate buﬀer,  pH5.0) were pipetted into 4 wells.  
Thirty µL of MPO substrate solution containing 
6mM 3, 3ʼ, 5, 5ʼ-tetramethylbenzidene dihydrochloride 
(TMBZ),  120µM resorcinol,  and 4.4mM H2O2 in 
distilled water was added to each well,  and the reac-
tion was stopped after 2min with 120µL of cold stop 
solution,  and the MPO activity was measured the 
absorbance at 450nm.  As an additional control,  90µL 
of dilution buﬀer (without liver extract) was pipetted 
into 4 wells,  followed by the addition of 30µL of 
substrate buﬀer,  and then,  after 2min,  120µL of 
stop solution.  No color reaction was observed in these 
control wells.  The MPO activity of the liver sample 
was calculated by subtracting the mean background 
absorbance and is expressed as the change in optical 
density per minute.
　 Nuclear extracts and Western blot analyses.
The nuclear fractions were obtained by the precipita-
tion of 25ｵ liver homogenate with 0.25M sucrose 
Tris-HCl buﬀer (pH7.4),  which was obtained by the 
centrifugation of 700×g for 10min at 4℃.  Then,  
this precipitation was resuspended in 50mM HEPES 
buﬀer (pH7.4) containing 0.1M KCl,  3mM magne-
sium chloride,  1mM ethylenediaminetetraacetic acid,  
10ｵ glycerol,  0.1mM phenylmethylsulfonyl ﬂuoride,  
5µg/mL pepstatin A,  5µg/mL leapeptin and 2µg/mL 
aprotinin,  and centrifuged at 22,000×g for 20min at 
4℃.  The supernatant was then used for the analysis 
of nuclear proteins.  The nuclear proteins were diluted 
to 6mg/mL,  then mixed with sample buﬀer (62.5mM 
Tris-HCl,  pH6.8,  containing 25ｵ glycerol,  2ｵ sodium 
dodecyl sulfate,  5ｵ 2-mercaptoethanol,  and 0.01ｵ 
bromophenol blue) and denatured at 95℃ for 5min.  
The samples (in 30µg protein/10µL) were separated 
on SDS-12.5ｵ polyacrylamide gel (Bio-Rad Labo-
ratories Inc.,  Hercules,  CA,  USA),  and then trans-
ferred to a polyvinylidene ﬂuoride (PVDF) membrane 
using a trans-blot apparatus (Bio-Rad Laboratories 
Inc. ).  The membranes were blocked in 5ｵ nonfat 
milk dissolved in TBS-T buﬀer (25mM Tris-HCl buf-
fer,  pH7.4,  containing 0.15M sodium chloride (NaCl) 
and 0.1ｵ Tween20) for 1h at room temperature,  and 
incubated with primary antibodies (mouse monoclonal 
anti-rat NF-κB p65 (1 : 1000 dilution) and rabbit 
polyclonal anti-rat Histone H1 (1 : 200 dilution);  
Santa Cruz Biotechnology,  Santa Cruz,  CA,  USA) 
overnight at 4℃,  and then incubated with secondary 
antibodies (goat anti-mouse antibody or goat anti-rab-
bit antibody (1 : 5000 dilution); Santa Cruz Bio-
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technology) for 0.5h at room temperature.  Visuali-
zation was performed with Chemiluminescence Luminol 
Reagent (Santa Cruz Biotechnology).  The quantity of 
NF-κB was corrected by that of Histone H1 in the 
same preparation.
　 Statistical analysis. Quantitative data were 
expressed as the mean±SEM.  The statistical analy-
sis was performed using a Studentʼs t-test or one-way 
ANOVA with Tukey.  A value of p＜0.05 was consid-
ered statistically signiﬁcant.
Results
　 Eﬀects of VCPL on body weights and liver 
indices. The body weights of rats in the NASH,  
NASH＋VCPL100,  and NASH＋VCPL300 groups,  
all of which were fed a CDHF diet,  signiﬁcantly 
decreased compared to those of the Control rats fed a 
standard chow diet.  There were no diﬀerences in body 
weights among the NASH,  NASH＋VCPL100,  and 
NASH＋VCPL300 groups (Table 1).  Calculating 
from the feed consumption,  there were also no diﬀer-
ences in the calorie intakes of the NASH,  NASH＋
VCPL100,  and NASH＋VCPL300 groups (319.3±
64.7,  323.5±68.8 and 317.3±65.5cal/kg/day,  respec-
tively),  while the caloric intake of the Control group 
(365.3±79.7cal/kg/day) was signiﬁcantly higher than 
those of each of the 3 experimental groups.
　 Compared to the Control rats,  there were decreases 
in the wet liver weights,  and increases in the liver 
indices in NASH rats,  as the weight decrease of the 
body counteracted that of the liver.  Further,  the body 
weights,  the wet liver weights and the liver indices 
were 248.5±9.7g and 12.2±1.3g and 4.9±0.8ｵ,  
respectively,  in the rats (n＝4) fed only CDHF with-
out intraperitoneal NaNO2 injections.  The VCPL 
administration induced signiﬁcantly greater decreases 
of the wet liver weights and the liver indices (p＜
0.01) in NASH rats.  Incidentally,  the rats adminis-
tered VCPL did not show any toxic responses such as 
body weight changes,  allergic responses like skin rash,  
or other organ injuries.
　 Eﬀects of VCPL on leakages of hepato-bil-
iary enzymes. The activities of ALT,  AST and 
ALP in plasma were signiﬁcantly (p＜0.01) elevated in 
the NASH group compared to the Control group.  The 
VCPL administration signiﬁcantly (p＜0.05) reduced 
the ALT elevation (Table 1).  The VCPL administra-
tion resulted in a tendency to reduce the AST and 
ALP activities of the NASH group,  however the dif-
ferences of activities between the groups without and 
with the VCPL administration,  were not statistically 
signiﬁcant.
　 Histopathological changes in liver. Histo-
logical examination of the livers of NASH rats pre-
pared by feeding with CDHF for 13 weeks in addition 
to NaNO2 treatment during the last 9 weeks revealed 
marked steatohepatitis (Fig 1.  B,  F),  compared with 
the Control group (Fig.  1A,  E).  Fatty change stained 
white was mostly a macrovesicular type,  involving all 
zones of the lobe.  Inﬂammatory inﬁltrates consisted of 
foci of acute and chronic inﬂammatory cells randomly 
distributed in the lobe.  Apparent ﬁbrosis of the liver 
was observed in all the groups except for the liver 
preparation of the Control group,  as the collagen-rich 
ﬁbrotic regions and the connective tissue are stained 
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Table 1　 Eﬀects of VCPL on body weight,  liver indices and leakages of hepato-biliary enzymes
NASH
Control 0 100VCPL (mg/kg/day,  p.o.) 300
Body weight (g) 414±9.3 225±8.1†† 231±8.6 233±7.2
Wet liver weight (g) 10±0.4 7.9±0.9 10±0.9 9.9±0.9
Liver index (%) 2.4±0.1 3.4±0.3† 4.5±0.3＊＊ 4.2±0.2＊＊
Biochemical marker (plasma)
　ALT (U/mL) 9.8±0.8 23.1±3.5†† 12.1±2.0＊ 14.4±1.3＊
　AST (U/mL) 101.1±8.3 422.0±19.3†† 420.0±35.6 346.0±10.0
　ALP (Released p-nitrophenol,  mM) 0.21±0.06 3.37±0.21†† 2.41±0.64 2.18±0.37
Each value denotes the mean±SEM for 6-8 rats except for the Control group (n＝5).  The liver index (%) was calculated as the wet liver 
weight/body weight ×100.  †p＜0.05,  ††p＜0.01 vs.  Control.  ＊p＜0.05,  ＊＊p＜0.01 vs.  NASH.
blue by Massonʼs trichrome stain.  The VCPL admin-
istration did not change the level of macrovesicular 
steatosis (Fig.  1C,  D) and abated liver ﬁbrosis (Fig.  
1G,  H).
　 The fat accumulation in hepatocytes of NASH rats 
was also quantiﬁed by the triglyceride contents,  which 
increased signiﬁcantly (p＜0.01) compared to those of 
Control rats.  The VCPL administration at the doses 
of 100mg and 300mg/kg/day had no eﬀect on triglyc-
eride contents in the liver of NASH rats (Fig.  1I).
　 As the collagen-rich ﬁbrotic regions and the con-
nective tissue are stained blue by Massonʼs trichrome 
staining,  there were detected the liver ﬁbrosis as the 
signiﬁcant increase of blue staining area in the liver 
tissue sections of NASH rats.  This signiﬁcant ﬁbrosis 
was ameliorated by VCPL administration (Fig.  1J).
　 Eﬀect of VCPL on plasma SOD-like activity.
The SOD-like activity in plasma was signiﬁcantly (p＜
0.05) reduced in the NASH group compared to the 
Control group (Fig.  2).  The reduced plasma SOD-like 
activity in NASH group was signiﬁcantly (p＜0.05) 
elevated by VCPL administration.
　 Eﬀect of VCPL on ROS derivation from liver 
mitochondria. The liver mitochondria of ROS 
derivation could be detected by signals from the 
DMPO-OH spin adducts in our ESR analysis.  The 
signal intensities were signiﬁcantly (p＜0.01) elevated 
in the NASH group compared to the Control group 
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Fig. 1　 Hepatic pathology in liver tissues of the experimental rats.  Liver tissue structure was assessed in the hematoxylin and eosin 
staining preparation of Control (A),  NASH (B),  NASH＋VCPL100mg/kg (C) and NASH＋VCPL300mg/kg (D) rats.  White regions show 
either the vascular cavity or fat accumulated hepatocytes.  Blue regions show collagen-rich parts,  either the ﬁbrosis or the connective tis-
sue around vessels,  in Massonʼs trichrome staining preparations of Control (E),  NASH (F),  NASH＋VCPL100mg/kg (G) and NASH＋
VCPL300mg/kg (H) rats.  Scale bar＝500µm.  The quantitative data of adiposity and ﬁbril formation in the liver are shown at I and J.  
Each value denotes the mean±SEM for 6-8 rats except for the Control group (n＝5).  ††p＜0.01 vs.  Control,  ＊p＜0.05 vs.  NASH.
(Fig.  3).  The high signal intensities in the NASH 
group were signiﬁcantly (p＜0.05,  p＜0.01) reduced by 
the VCPL administration in a dose-dependent manner.
　 Eﬀect of VCPL on MPO activity in the liver.
MPO activity in the liver as an indicator of neutrophil 
inﬁltration was signiﬁcantly (p＜0.01) elevated in the 
NASH group compared to the Control group (Fig.  4).  
The elevated MPO activities in the NASH group were 
signiﬁcantly (p＜0.05,  p＜0.01) reduced by the VCPL 
administration in a dose-dependent manner.
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Fig. 3　 Eﬀects of VCPL on the mitochondrial ROS derivation from rat liver.  ESR spectra of DMPO-OH spin adducts were detected by 
the mixtures of the mitochondrial respiratory substrates with the liver mitochondrial preparations of Control,  NASH,  NASH＋VCPL100 and 
NASH＋VCPL300 rats denoted at the right.  Each value denotes the mean±SEM for 6-8 rats except for Control group (n＝5).  ††p＜0.01 
vs.  Control.  ＊p＜0.05,  ＊＊p＜0.01 vs.  NASH.
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Fig. 2　 Eﬀects of VCPL on plasma SOD-like activity of rats.  ESR spectra of DMPO-OOH spin adducts were detected by the mixtures of 
O2•ﾝ generating systems with the plasma samples of Control,  NASH,  NASH＋VCPL100 and NASH＋VCPL300 rats denoted at the right.  
Each value denotes the mean±SEM for 6-8 rats except for Control group (n＝5).  †p＜0.05 vs.  Control.  ＊p＜0.05 vs.  NASH.
　 Eﬀect of VCPL on the expression of NF-κB 
p65 protein. The activation of NF-κB was mea-
sured according to the amount of NF-κB in the 
nucleus by Western blotting analysis of the nuclear 
protein of rat liver.  Signiﬁcant NF-κB activation (p
＜0.01) was demonstrated by the increased NF-κB p65 
band in the NASH group compared to that in the 
Control group (Fig.  5).  The increased NF-κB incor-
poration into the nuclei in the hepatocytes of NASH 
group was signiﬁcantly (p＜0.01) decreased by VCPL 
administration.
Discussion
　 This is the ﬁrst study to show that VCPL is able 
not only to prevent the development of NASH,  but 
also to ameliorate the condition once developed.  The 
present study demonstrated that oral VCPL adminis-
tration for NASH model rats with advanced liver 
ﬁbrosis could lessen the leakages of hepato-biliary 
enzymes (Table 1),  but also could ameliorate the 
condition once developed.  Further,  VCPL was shown 
to be able to correct the oxidative stress enhancement 
in NASH rats,  to regain the decrease of plasma anti-
oxidative abilities and to ameliorate the increase of 
mitochondrial ROS derivation.
　 The water extracts from green leaves were also 
suggested to be eﬀective,  because there was no sig-
niﬁcant diﬀerence between the abilities of red and 
green leaves to scavenge oxygen free radicals in vitro 
(data not shown).  In contrast,  the water extracts from 
red leaves post-harvest were superior in palatability 
and there was no inﬂuence on the fruit yield.  There-
fore,  in the present study we used the red leaves 
post-harvest.
　 Compared to those of the Control group,  the body 
weights decreased in the NASH groups fed a CDHF 
diet,  independent of VCPL administration.  This 
decrease would have resulted from a decrease in 
caloric intake,  since the CDHF diet was in paste form 
and more diﬃcult to eat than a standard solid diet.  
Thus,  the VCPL can be considered safe as a food for 
human consumption,  since its administration did not 
induce a change in the body weights of NASH rats or 
any toxic responses such as allergy or other organ 
injuries,  including kidney injuries (data not shown),  in 
addition to its having been a traditional food in the 
Hiruzen district of Okayama since ancient times.
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Fig. 5　 Eﬀects of VCPL on NF-κB activation in hepatocytes of 
rats.  By the activation,  NF-κB is imported into the nuclear fraction.  
The levels of NF-κB p65 and Histone H1 in the nuclear fraction of 
hepatocytes were measured by Western blot.  The band density of 
NF-κB was compensated by the respective Histone H1,  and further 
the data were shown on the basis of Control group.  Each value 
denotes the mean±SEM for 6-8 rats except for Control group (n＝
5).  ††p＜0.01 vs.  Control,  ＊＊p＜0.01 vs.  NASH.
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Fig. 4　 Eﬀects of VCPL on the myeloperoxidase activities of rat 
liver.  Myeloperoxidase (MPO) activity as a marker of neutrophil 
inﬁltration was detected with absorbance at 540nm.  Each value 
denotes the mean±SEM for 6-8 rats except for Control group (n
＝5).  ††p＜0.01 vs.  Control,  ＊p＜0.05,  ＊＊p＜0.01 vs.  NASH.
　 In our NASH model,  the pathologic conditions 
were ameliorated by the dissolution of choline deﬁ-
ciency,  because the fatty liver formation was acceler-
ated by a CDHF diet,  to prepare NASH for a short 
term.  However,  the choline deﬁciency was not relieved 
by the VCPL administrations,  as its content in VCPL 
was 0.6mg/g freeze-dried preparation.  The 300mg/
kg/day VCPL administration supplies choline at a 
dose of 0.018mg/kg/day,  while the standard diet 
contains 2mg/g choline.
　 A hydrophilic reagent,  NaNO2,  was injected intra-
peritoneally,  to provoke methemoglobinemia and decay 
the oxygen transport ability,  which induced the inter-
mittent hypoxemia.  A direct reaction between NaNO2 
and VCPL was hardly expected,  because the interval 
of both administrations was 3h.  Rather,  it was sug-
gested that VCPL would improve methemoglobinemia 
by increasing the antioxidative defense abilities,  such 
as the elevation of SOD-like activity (Fig.  2),  which 
in turn would increase the reduced glutathione.
　 Oxidative stress-related injury has been considered 
a likely basal process in the progression of hepatocel-
lular damage,  inﬂammation,  and ﬁbrosis [15-18].  
Although there have been many reports of food ingre-
dients with antioxidative activities that can prevent 
clinical progression of NASH,  including green tea 
extracts [19],  fermented green tea extracts [20] and 
N-acetylcysteine [21],  these ingredients have not been 
shown to have eﬀects on treated progressive NASH.
　 In comparison with Control rats,  the liver indices 
exhibited hepatomegaly (4.9±0.8ｵ) in rats only fed 
CDHF without NaNO2 injections that corresponded to 
the fatty liver status without severe ﬁbrosis (data not 
shown).  Compared to the liver index of 4.9±0.6ｵ 
described above,  that of NASH rats (3.4±0.3ｵ;  
Table 1) indicated liver atrophy.  VCPL administra-
tion alleviated the liver atrophy that indicated the 
lessened ﬁbrosis,  compared with NASH rats (Table 
1,  Fig. 1).  Therefore,  these ﬁndings indicated that 
VCPL could improve NASH by inhibition of “second 
hits”.
　 In addition,  previous studies identiﬁed the pig-
ments in the fruit and peel of Vitis coignetiae Pulliat as 
mostly malvidin-3,  5-diglucoside and malvidin-3,  
5-diglucoside-coumarate [22].  Some studies have deﬁned 
anthocyanins as having remarkable antioxidative and 
oxygen radical-scavenging properties [23,  24].  Pre-
vious studies on leaves from European grapes (Vitis 
vinifera L. ) showed antihyperglycemic eﬀects in dia-
betic rats [25,  26] and hepatoprotective activities 
[27,  28].  These ﬁndings would thus support the ﬁnd-
ing in this study that the anthocyanins in VCPL also 
conferred hepatoprotective eﬀects in NASH rats.
　 MPO is a well-known enzyme associated with the 
generation of reactive oxygen/nitrogen species and 
inﬂammation that lead to the progression of human 
NASH [29].  This study demonstrated that MPO 
activity was signiﬁcantly elevated in the livers of rats 
with NASH (Fig.  4).  In addition,  this study showed 
an increase in mitochondrial ROS derivation in the 
livers of NASH rats (Fig.  3).  Some studies have 
reported an association between mitochondrial dys-
function and NASH [30,  31].  The present results 
also indicate that the increased MPO activity in 
Kupﬀer cells and the liver mitochondrial dysfunction 
induced the oxidative damage in NASH.  Whereas rats 
supplied VCPL showed an increase in SOD-like activ-
ity in plasma (Fig.  2),  and showed a decrease of MPO 
activity and mitochondrial ROS derivation in the liver.
　 It has been reported that the SOD activities in mice 
and rats are increased by the oral administration of the 
fruit,  peel and seeds of grapes [32,  33],  and by 
VCPL in our previous study to examine the preven-
tive eﬀect on NASH [12].  Though it is unclear what 
substances elevate the plasma SOD-like activity by 
VCPL administration,  we expect that the elevation 
reﬂects the antioxidative constituents absorbed from 
the gastrointestinal tract into circulation or,  through 
them,  the preservation of endogenous antioxidants.  
Therefore,  further studies are necessary to identify 
this ingredient in VCPL.  Nevertheless,  the present 
results have shown that VCPL administration could 
help to slow the progress of NASH by scavenging 
ROS,  by correcting the excess generation of ROS,  or 
by both these actions.
　 Inﬂammation is thought to also be a key element in 
the progression of NASH,  and intimately related to 
OS.  Activation of NF-κB is particularly critical for 
the development of inﬂammation under a variety of 
conditions [34].  NF-κB is also reported to be an 
OS-responsive transcription factor [35-37].  In fact,  
OS is invariably recognized in the liver of patients 
with NASH [37-39] and in several rodent models of 
steatohepatitis [40,  41].  The present study showed 
that the NF-κB expression in the nuclear fraction of 
hepatocytes increased (Fig.  5) in correspondence with 
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the elevation of mitochondrial ROS derivation in 
NASH rats.  And these levels were decreased by 
VCPL administration respectively.  Thus we suggest 
that VCPL inhibited activation of NF-κB by regulat-
ing OS,  leading to slow the progress of NASH.
　 This study is the ﬁrst to demonstrate that VCPL 
can ameliorate NASH in the progressive stage by 
increasing plasma antioxidative activity,  decreasing 
the ROS derivation from mitochondrial energy metabo-
lism and reducing the NF-κB activation in a rat model,  
suggesting that OS-induced damage and inﬂammation 
are associated with the progressive NASH.  Further 
studies are required to determine the mechanisms 
underlying the beneﬁcial eﬀect of the antiﬁbrotic 
activity of VCPL on progressive NASH,  as well as to 
assess the serial changes in mitochondrial function and 
liver architecture in the NASH livers.
　 In conclusion,  this study demonstrated that the 
antioxidative activity of VCPL seems to improve 
progressive NASH by breaking the crosstalk between 
OS and inﬂammation,  suggesting that VCPL is a novel 
functional food to slow the progress of NASH.
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